G J van Steenbergen1, D van Veghel2, D N Schulz2, M Soliman-Hamad3, P A Tonino2, S Houterman3,4, L Dekker2,5. 1. Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands. gijs.v.steenbergen@catharinaziekenhuis.nl. 2. Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands. 3. Department of Cardiothoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands. 4. Netherlands Heart Registration (NHR), Utrecht, The Netherlands. 5. Department of Biomedical Technology, Eindhoven University of Technology, Eindhoven, The Netherlands.
Abstract
OBJECTIVE: The aim of this study is to assess the effects on procedural, 30-day, and 1‑year all-cause mortality by a newly introduced quality improvement strategy in patients after transcatheter aortic valve replacement (TAVR). METHODS: In October 2015, a coherent set of quality improving interventions with respect to patient geriatric screening, general diagnostic examination and safety of the procedure was implemented at a single centre in the Netherlands. Patients undergoing TAVR in 2013-2018 were included for retrospective analysis. Mortality was assessed in the pre-quality improvement strategy cohort (January 2013 to October 2015; cohort A) and in the post-quality improvement strategy cohort (November 2015 to December 2018; cohort B). Logistic regression analysis was used to estimate the influence of patient and procedural characteristics on the results of the quality improvement strategy in terms of procedural, 30-day, and 1‑year all-cause mortality. RESULTS: In total, 806 patients were analysed with 274 patients in cohort A and 532 patients in cohort B. After introduction of the quality improvement strategy, procedural (4.4% to 1.3%, p < 0.01), 30-day (8.4% to 2.7%, p < 0.01) and 1‑year (16.4% to 8.5%, p < 0.01) all-cause mortality significantly decreased. Multivariate regression analysis showed that the quality improvement strategy also significantly reduced 30-day (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.09-0.42) and 1‑year (OR 0.38, 95% CI 0.24-0.61) all-cause mortality if corrected for patient characteristics. CONCLUSION: Structural meetings on evaluation of outcomes highlight potential areas for improvement and subsequent outcome-based quality improvement initiatives can result in lower procedural, 30-day, and 1‑year all-cause mortality.
OBJECTIVE: The aim of this study is to assess the effects on procedural, 30-day, and 1‑year all-cause mortality by a newly introduced quality improvement strategy in patients after transcatheter aortic valve replacement (TAVR). METHODS: In October 2015, a coherent set of quality improving interventions with respect to patient geriatric screening, general diagnostic examination and safety of the procedure was implemented at a single centre in the Netherlands. Patients undergoing TAVR in 2013-2018 were included for retrospective analysis. Mortality was assessed in the pre-quality improvement strategy cohort (January 2013 to October 2015; cohort A) and in the post-quality improvement strategy cohort (November 2015 to December 2018; cohort B). Logistic regression analysis was used to estimate the influence of patient and procedural characteristics on the results of the quality improvement strategy in terms of procedural, 30-day, and 1‑year all-cause mortality. RESULTS: In total, 806 patients were analysed with 274 patients in cohort A and 532 patients in cohort B. After introduction of the quality improvement strategy, procedural (4.4% to 1.3%, p < 0.01), 30-day (8.4% to 2.7%, p < 0.01) and 1‑year (16.4% to 8.5%, p < 0.01) all-cause mortality significantly decreased. Multivariate regression analysis showed that the quality improvement strategy also significantly reduced 30-day (odds ratio [OR] 0.19, 95% confidence interval [CI] 0.09-0.42) and 1‑year (OR 0.38, 95% CI 0.24-0.61) all-cause mortality if corrected for patient characteristics. CONCLUSION: Structural meetings on evaluation of outcomes highlight potential areas for improvement and subsequent outcome-based quality improvement initiatives can result in lower procedural, 30-day, and 1‑year all-cause mortality.
Entities:
Keywords:
Cardiology; Multidisciplinary meeting; Outcome-based quality improvement; Quality committee; Quality improvement; TAVR; Value based health care
Authors: Stefan Stortecky; Andreas W Schoenenberger; André Moser; Bindu Kalesan; Peter Jüni; Thierry Carrel; Seraina Bischoff; Christa-Maria Schoenenberger; Andreas E Stuck; Stephan Windecker; Peter Wenaweser Journal: JACC Cardiovasc Interv Date: 2012-05 Impact factor: 11.195
Authors: L Lehmkuhl; B Foldyna; M Haensig; K von Aspern; C Lücke; C Andres; M Grothoff; F Riese; S Nitzsche; D Holzhey; A Linke; F-W Mohr; M Gutberlet Journal: Rofo Date: 2013-09-02
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard A Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Robert O Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasché; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; José-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michael Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis Journal: Eur Heart J Date: 2012-08-24 Impact factor: 29.983
Authors: Anthony W A Wassef; Josep Rodes-Cabau; Yaqing Liu; John G Webb; Marco Barbanti; Antonio J Muñoz-García; Corrado Tamburino; Antonio E Dager; Vicenç Serra; Ignacio J Amat-Santos; Juan H Alonso Briales; Alberto San Roman; Marina Urena; Dominique Himbert; Lius Nombela-Franco; Alexandre Abizaid; Fabio S de Brito; Henrique B Ribeiro; Marc Ruel; Valter C Lima; Fabian Nietlispach; Asim N Cheema Journal: JACC Cardiovasc Interv Date: 2018-09-10 Impact factor: 11.195
Authors: Norbert Frey; Richard P Steeds; Antonio Serra; Eberhard Schulz; Stephan Baldus; Matthias Lutz; Christiane Pohlmann; Jana Kurucova; Peter Bramlage; David Messika-Zeitoun Journal: BMC Cardiovasc Disord Date: 2017-01-05 Impact factor: 2.298
Authors: F van Kesteren; M S van Mourik; E M A Wiegerinck; J Vendrik; J J Piek; J G Tijssen; K T Koch; J P S Henriques; J J Wykrzykowska; R J de Winter; A H G Driessen; A Kaya; R N Planken; M M Vis; J Baan Journal: Neth Heart J Date: 2018-09 Impact factor: 2.380